Introduction
============

*Staphylococcus aureus*, as a leading bacterial agent of a series of hospital- and community- acquired infections, has been listed as a pathogen with high priority for research and development of new antibiotics ([@B78]). Fail of eradication of *S. aureus* in clinical treatments is linked to persister formation. Persisters, first observed in staphylococci in [@B32], are defined as a subpopulation of bacterial cells that, without undergoing genetic changes, survive the effects of high concentration of bactericidal antibiotics ([@B6]). Persisters have been associated with persistent infections, presenting severe threats to patients with bacterial infections ([@B42]; [@B23]; [@B81]).

The last decade has seen much research on the mechanisms of persister formation, most of which was derived from *Escherichia coli*. Genes involved in toxin--antitoxin modules, *trans*-translation, energy production, stringent response and efflux have been found to be involved in persister formation by inducing dormancy ([@B21]; [@B37]; [@B46]; [@B43]; [@B65]). The most in-depth study so far, though not necessarily the most important, is on HipAB module in *E. coli.* Mutated HipA augments persister formation by phosphorylation of GltX, which in turn raises concentration of uncharged tRNA^Glu^, induces production of (p)ppGpp and polyP, and eventually promotes persister formation with increased production of toxins including HipA, RelE, MazF, and YafQ ([@B39]; [@B47]; [@B27]; [@B53]). A recent study revealed a similar mechanism that a toxin TacT promotes persister formation via acetylation of tRNA in *Salmonella enterica* serovar Typhimurium ([@B12]). Research on persister formation has also been performed in other bacteria, including *Pseudomonas aeruginosa*, *Streptococcus mutans* and *Staphylococcus aureus* ([@B72]; [@B57]; [@B41]).

Previous studies showed that the characteristics and mechanisms of persisters in *S. aureus* are different from those in *E. coli*. The higher portion of persisters in stationary phase and clinical impact of Staphylococcus persisters has drawn increasing attention recently ([@B23]; [@B40]). It takes more time to show distinct killing of *S. aureus* cells, and an iconic feature of *E. coli* persisters, called biphasic killing curve, is often absent in treatment of stationary phase *S. aureus* cultures with antibiotics ([@B40]; [@B14]; [@B79]). Multiple genes have been reported to be associated with Staphylococcus persister formation ([@B50]; [@B77]; [@B80]; [@B79]). In addition, L-forms that survive high concentration of antibiotics with cell wall deficiency are believed to be a special kind of persisters ([@B29]). It is intriguing that few of the homologous genes of many *E. coli* persister genes affect persister formation in *S. aureus*. A typical case is that no mutation of known TA modules in *S. aureus* affects persister levels ([@B15]). In addition, the ppGpp molecule is not as important in *S. aureus* persister formation as in *E. coli* ([@B25]; [@B17]). Nonetheless, it is worth noting that besides specific genes, decreased ATP level during entry into stationary phase is found to be a key reason of persister increase in both *E. coli* and *S. aureus* ([@B15]; [@B70]).

Besides the difference of persister genes between *E. coli* and *S. aureus*, the regulatory mechanism of *S. aureus* persister formation also remains elusive. Persister formation has been defined as an outcome of stochastic induction of toxin-antitoxin activity and other persister genes influenced by the level of p(ppGpp) which varies stochastically in different cells during growth ([@B47]; [@B27]). However, some key aspects of stochastic theory are unclear, especially the initiation of persister formation. QS, for its manner of regulation, is a candidate for this kind of regulation. In *P. aeruginosa* and *S. mutans*, regulation of QS has been reported ([@B54]; ?). However, whether the QS system is involved in *S. aureus* persister formation needs to be determined.

There are two known QS systems in *S. aureus*, LuxS and Agr. Agr is a master regulator of virulence, activated by an autoinducing peptide (AIP) that is encoded by *agrD* and modified and exported by AgrB ([@B33]; [@B56]). Extracellular AIP molecules are processed by a TCS consisting of the histidine kinase AgrC and the response regulator AgrA ([@B44]). While most of downstream virulence genes are regulated through RNAIII, AgrA directly regulates several metabolic pathways including carbohydrate and amino acid metabolism ([@B22]; [@B83]; [@B66]). Also, Agr particularly controls expression of three specific group of virulence factors named PSMs ([@B76]; [@B64]), which are transported by the Pmt system ([@B10]). [@B34] has recently reported that PSMs bind PmtR, the transcription repressor of the Pmt system, and hence promote expression of PSM transporters, showing that PSMs not only function as toxins but act as signals to regulate gene expression of *S. aureus*.

The correlation between persister formation and persistent infection is drawing increasing attention. Multiple observations of persisters in clinical infections have been reported in *E. coli*, *S. aureus*, *P. aeruginosa*, and *Mycobacterium tuberculosis* ([@B19]; [@B82]; [@B13]). High expression of HipA promotes persister formation and thus cause multidrug tolerance in urinary tract infections by *E. coli* ([@B68]). Despite clinical observations, a recent study showed that awakened *S. aureus* persisters are able to initiate infections and that *S. aureus* persisters, whether awake or not, possess advantages escaping from engulfment of macrophages ([@B52]), supporting the notion that persisters are important in initiating and establishing infections. Hence, understanding the mechanisms of *S. aureus* persister formation is critical for development of new strategies against the dangerous pathogen.

Here we report that Agr is a repressor of persister formation in stationary phase *S. aureus*. The modulation of persister formation by Agr is not RNAIII dependent, but relies on regulation of PSM expression. The findings provide new insights into the pathogenesis of *S. aureus* and clinical treatment of *S. aureus* infections.

Materials and Methods {#s1}
=====================

Strains, Reagents, and Growth Conditions
----------------------------------------

*Staphylococcus aureus* MRSA strain USA500 ([@B20]) as well as MSSA strains HG003 ([@B31]) and Newman ([@B4]) were used as wild type strains. *E. coli* DC10B ([@B55]) was used for shuttle plasmid construction (**Table [1](#T1){ref-type="table"}**). All manipulations of the strains were carried out in biosafety level 2 labs.

###### 

Strains and plasmids used in this study.

  Strain/plasmid   Specification                                                     Reference
  ---------------- ----------------------------------------------------------------- ------------
  **Strains**                                                                        
  DC10B            A DC10B derivate for plasmid amplification                        [@B55]
  USA500           MRSA strain from a clinical sample                                [@B20]
  Newman           An MSSA strain from a clinical sample                             [@B4]
  HG003            An MSSA strain, derivate from NCTC8325                            [@B31]
  ΔAgrCA           The *agrCA* mutant of USA500                                      This study
  NewmanΔAgrCA     The *agrCA* mutant of Newman                                      This study
  HG003ΔAgrCA      The *agrCA* mutant of HG003                                       This study
  ΔAgrD            The *agrD* mutant of USA500                                       This study
  ΔRNAIII          The *RNAIII* mutant of USA500                                     This study
  ΔluxS            The *luxS* mutant of USA500                                       This study
  ΔArlRS           The *arlRS* mutant of USA500                                      This study
  ΔGraRS           The *graRS* mutant of USA500                                      This study
  ΔNanK            The *nanK* mutant of USA500                                       This study
  ΔAgrCAΔNanK      The *agrCA* mutant of USA500 with additional knockout of *nanK*   This study
  ΔHutU            The *hutU* mutant of USA500                                       This study
  ΔNarG            The *narG* mutant of USA500                                       This study
  ΔArcA            The *arcA* mutant of Newman                                       This study
  ΔArcR            The *arcR* mutant of Newman                                       This study
  ΔMtlD            The *mtlD* mutant of Newman                                       This study
  ΔImrP            The *imrP* mutant of Newman                                       This study
  ΔRhbC            The *rhbC* mutant of Newman                                       This study
  ΔIpdC            The *ipdC* mutant of Newman                                       This study
  **Plasmids**                                                                       
  pRAB11           ATc inducible shuttle plasmid, Cm^R^, Amp^R^                      [@B30]
  pMX10            A pKOR1 derivate for gene knockout, Cm^R^, Amp^R^                 This study
  pRB473           A shuttle plasmid for complementary construction, Cm^R^, Amp^R^   [@B7]
  pRBagrCA         Complementary plasmid for AgrCA                                   This study
  pRBagrD          Complementary plasmid for AgrD                                    This study
  pRBnanK          Complementary plasmid for NanK                                    This study
  pRABpsmα         Overexpression plasmid for *psmα1-4*                              This study
  pRABpsmβ         Overexpression plasmid for *psm*β*1-2*                            This study
  pRABpsmαβ        Overexpression plasmid for *psmα1-4* and *psm*β*1-2*              This study

Cm

R

, chloramphenicol resistance; Amp

R

, ampicillin resistance

.

Lysogeny broth (LB) was used for cultivation of *E. coli* strains. TSB (Tryptic soy broth, Oxoid) were used for *S. aureus* cultivation. Anhydrotetracycline (ATc) (Sigma) was used for induction of *secY* antisense RNA during screening of mutants. During cultivation of strains that carry antibiotic resistance genes, antibiotics were added to medium at the following concentrations: chloramphenicol, 10 μg/μl; ampicillin, 100 μg/μl.

All strains were cultured at 37°C with shaking at 180 rpm unless otherwise specified. Growth curves were determined by measuring the optical density (OD) values at 600 nm every hour.

Gene Knockout, Complementation, and Overexpression
--------------------------------------------------

Plasmid pMX10 ([@B79]), a derivate of pKOR1 ([@B5]), was used for gene knockout in *S. aureus*. Plasmid pRB473 ([@B7]) was used for complementation of gene mutations. Plasmid pRAB11 ([@B30]) was used for inducible expression of target genes. Q5 DNA polymerase (NEB) was used for all PCR experiments and restriction enzymes (NEB) for construction of recombinant plasmids in this study. Additional information of plasmids used in this study can be found in **Table [1](#T1){ref-type="table"}**.

All sequences of primers are listed in Supplementary Table [S1](#SM5){ref-type="supplementary-material"}. To construct knockout mutants, upstream and downstream fragments of each gene were amplified with primers uf+ur and df+dr, respectively, using genome DNA of HG003, USA500 or Newman as templates. The two fragments were then used as templates to amplify a fusion fragment, which was ligated into pMX10 with T4 DNA ligase (Thermo Fisher Scientific) after digestion with corresponding restriction enzymes (Thermo Fisher Scientific). The recombinant plasmids were purified from DC10B and introduced into *S. aureus* via electro transformation. Selection of mutants were carried out following the protocol previously published ([@B5]).

To construct complementary strains, genes with their own promoters were amplified from USA500 genomic DNA. Since the coding sequences of *agrCA* and *agrD* are not directly attached to that P2 promoter of *agr* operon, we fused the P2 promoter sequence and the coding sequence of *agrCA* or *agrD*, similar with construction of knockout plasmids described above. The PCR products were digested with corresponding restriction enzymes and ligated into pRB473. To construct plasmids for inducible overexpression, the full sequence of *psmα1-4* or *psm*β*1-2* were amplified and inserted into pRAB11. For co-expression of PSMαs and PSMβs, the coding sequences of *psmα1-4* and *psm*β*1-2* were fused and cloned into pRAB11. The resultant plasmids were transformed to each mutant strain via electro transformation.

Susceptibility Testing
----------------------

The MIC of each antibiotic was determined in TSB medium by the conventional broth micro dilution technique. The experiments were executed in triplicate according to the protocol previously published ([@B2]), following the CLSI guidelines. The MIC was defined as the lowest antibiotic concentration that inhibited visible bacterial growth after 24 h of incubation at 37°C.

Persister Assay
---------------

To obtain exponential cultures, overnight *S. aureus* strains were inoculated by 1:100 into TSB and cultured for about 1.5 h to an OD600 of 0.5--0.6. Stationary phase cultures were grown to ∼14 h. For complementary strains, the cultures were grown in TSB with 10 μg/μl chloramphenicol. For strains for inducible overexpression, 125 ng/μl ATc was added to each sample at 6 h. After washing twice with PBS, cultures were allotted in 14 μl tubes and challenged with one of the four antibiotics: levofloxacin at 50 μg/μl, gentamicin at 50 μg/μl, oxacillin at 5 μg/μl, and vancomycin at 50 μg/μl. Serial dilutions were performed and 100 μl aliquots were spotted on TSA plates for colony-forming unit (CFU) counting at different time points. Results were obtained from three biological duplicates and significance was assessed with *t*-test.

RNA Isolation, mRNA Enrichment and Sequencing
---------------------------------------------

*Staphylococcus aureus* strain USA500, Δ*agrD*, Δ*agrCA*, and Δ*RNAIII* were incubated for 14 h and harvested. Total RNA was purified following protocol previous reported ([@B3]). Briefly, cultures were centrifuged, resuspended in 100 μl diethylpyrocarbonate (DEPC) H~2~O. Each aliquot was added with 100 μl phenol/chloroform (1:1), incubated at 70°C for 30 min and centrifuged. RNA was purified from the supernatant of each sample using RNeasy Mini Kit (Qiagen), following protocol provided.

The Bioanalyzer 2100 RNA-6000 Nano Kit (Agilent Technologies) was used to detect the quality of total RNA. The Ribo-Zero^TM^ Gold Kit (Illumina) was used to remove 16S and 23S rRNAs. The cDNA libraries with cDNA length ranging from 150 to 250 bp were generated from the mRNA samples using the TruSeq Illumina Kit (Illumina), following instructions from the manufacturer.

RNA-seq was performed by Shanghai Biotechnology Corporation (Shanghai, China) with HiSeq2500 Ultra-High-Throughput Sequencing System (Illumina). The total numbers of reads were assessed and quantified with the Cufflinks suite of tools. The transcript sequencing data were submitted to the NCBI Sequence Read Archive and deposited under the accession number [SRR5277864](SRR5277864).

Quantitative Real-Time PCR
--------------------------

For qRT-PCR, RNA samples were extracted from *S. aureus* strains as described above. Reverse transcription was carried out using the cDNA Synthesis Kit (Bio-Rad, United States). The qRT-PCR experiments were performed using SYBR Green PCR Kit (Takara) on Applied Biosystems 7500 Real-Time PCR System (Thermo Fisher Scientific). The sequences of primers for detection of target genes and primers for endogenous control gene *rrs1* (16S RNA) are listed in Supplementary Table [S1](#SM6){ref-type="supplementary-material"}. The 2^-ΔΔC~T~^ method ([@B45]) was used for analysis of relative gene expression data that were obtained from three independent experiments.

L-Form Assay
------------

L-form test was performed following protocol previously published ([@B29]). Briefly, L-form induction medium (LIM) was prepared with brain heart infusion (BHI) supplemented with 1% agar, 10% fetal bovine serum (Gibco, United States), 3.5% sodium chloride, 20% sucrose, 0.125% magnesium sulfate, and 600 μg (1000 units)/μl of Penicillin G (Sigma). *S. aureus* Newman strain was grown overnight to stationary phase. Undiluted cultures were spotted onto LIM and incubated at 33°C for 7--10 days. The L-form colonies were detected by inverted microscope (Nikon).

Measurement of Intracellular ATP Level
--------------------------------------

Stationary phase cultures of *S. aureus* strains were mixed with BacTiter-Glo^TM^ reagent from the BacTiter-Glo^TM^ Microbial Cell Viability Assay (Promega, United States) by 1:1. The luminescence was detected with an FB12 luminometer (Berthold). Data was neutralized according to CFU counting of each culture.

Statistics
----------

The significance of experimental differences in persister assay and intracellular ATP assay was evaluated with two-tailed unpaired *t*-test (two groups).

Results
=======

Agr System Regulates Persister Formation
----------------------------------------

We constructed mutants via homologous recombination for Agr and LuxS QS systems, as well as two TCSs ArlRS and GraRS involved in virulence regulation. Considering the complexity of Agr system, mutation of the AIP coding gene *agrD* and the Agr controlled regulatory RNA molecule gene *RNAIII* were also constructed (**Table [2](#T2){ref-type="table"}**). The growth of each mutant strain of USA500 was measured. As shown in **Figure [1A](#F1){ref-type="fig"}**, none of the knockout mutants affected bacterial growth, indicating these genes are not required for normal bacterial growth in log phase.

###### 

Genes detected for persister formation in this study.

  Gene ID                              Gene       Function                                         Parent   Persister-   Persister-
  ------------------------------------ ---------- ------------------------------------------------ -------- ------------ ------------
  **Regulators**                                                                                                         
  *USA300HOU_2034, USA300HOU_2035*     *agrCA*    Two-component system                             USA500   --           ↑
  *NWMN_1945, NWMN_1946*               *agrCA*    Two-component system                             Newman   --           ↑
  *SAOUHSC_02264, SAOUHSC_02265*       *agrCA*    Two-component system                             HG003    --           ↑
  *USA300HOU_2033*                     *agrD*     Signal peptide precursor                         USA500   --           ↑
  *USA300HOU_nc0020*                   *RNAIII*   Regulatory RNA, includes *hld coding sequence*   USA500   --           ↓
  *USA300HOU_2123*                     *luxS*     Quorum sensing                                   USA500   --           --
  **Transcription regulators**                                                                                           
  *USA300HOU_0680*, *USA300HOU_0681*   *graRS*    Two-component system                             USA500   --           --
  *USA300HOU_1350*, *USA300HOU_1349*   *arlRS*    Two-component system                             USA500   --           --
  **Metabolism genes**                                                                                                   
  *USA300HOU_0336*                     *nanK*     ManNAc kinase                                    USA500   --           ↓
  *USA300HOU_2311*                     *hutU*     Urocanate hydratase                              USA500   --           --
  *USA300HOU_2379*                     *narG*     Nitrate reductase                                USA500   --           --
  *NWMN_2534*                          *arcA*     Arginine deiminase                               Newman   --           --
  *NWMN_2530*                          *arcR*     Arginine metabolism regulator                    Newman   --           --
  *NWMN_2060*                          *mtlD*     mannitol-1-phosphate 5-dehydrogenase             Newman   --           --
  *NWMN_0122*                          *imrP*     Transporter                                      Newman   --           --
  *NWMN_2082*                          *rhbC*     Sialic synthase                                  Newman   --           --
  *NWMN_0132*                          *ipdC*     Indole-3-pyruvate decarboxylase                  Newman   --           

↑, increase; ↓, decrease; --, no significant difference

.

![Agr system regulates *S. aureus* persiser levels. **(A,C)** Growth curve of different knockout strains compared with their parent strains. **(B,D)** Stationary phase cultures of knockout strains and the parent strains were treated with 50 μg/μl levofloxacin. The limit of detection was 100 CFU/μl throughout all killing experiments. Results are representative of three independent experiments.](fmicb-08-02189-g001){#F1}

To address the role of the above genes in persister formation, several antibiotics were used to treat exponential phase cultures of USA500 and the mutant strains. As a result, none of the mutants affected persister formation to any of the antibiotics (**Supplementary Figures [S1A--D](#SM1){ref-type="supplementary-material"}**). Stationary cultures of MRSA can be extremely difficult to kill by multiple antibiotics, even after 5-day treatment at high concentrations of antibiotics ([@B40]; [@B14]). Based on our previous observation that levofloxacin can cause prominent killing of *S. aureus* USA500 strain ([@B79]), we used levofloxacin in persister assays of stationary phase cultures in this study. Among the strains, USA500 Δ*agrCA* or USA500 Δ*agrD* showed significant increase of persister formation to levofloxacin in stationary phase while knockout of *RNAIII* slightly reduced persister formation. At the 5th day of treatment, the CFU count of USA500 Δ*agrCA* or USA500 Δ*agrD* dropped ∼1 log~10~ compared to that of the 1st day, while the CFU count of USA500 ΔRNAIII (∼10 CFU/μl) was even lower than that of the control strain USA500 (∼10^2^ CFU/μl). The impacts of knockout of *agrCA* or *agrD* were reversed by complementation of each gene (**Figure [1B](#F1){ref-type="fig"}**). Mutation in *luxS*, *arlRS*, or *graRS* showed no apparent impact on persister formation of stationary phase cultures (**Supplementary Figure [S1E](#SM1){ref-type="supplementary-material"}**).

To investigate whether the impact on persister formation by Agr system is ubiquitous in *S. aureus*, we constructed *agrCA* mutants in two methicillin sensitive *S. aureus* (MSSA) strains Newman and HG003. While none of the knockout mutations affected growth (**Figure [1C](#F1){ref-type="fig"}**), both mutant strains showed augmented persister formation in stationary phase, but only to levofloxacin (**Figure [1D](#F1){ref-type="fig"}**).

RNA-seq Analysis of Stationary Phase Regulation by Agr System
-------------------------------------------------------------

The Agr system functions by regulating expression of its target genes, either by direct regulation with AgrA or by indirect regulation through RNAIII ([@B26]; [@B66]). As we have shown, the difference in bacterial survival between Δ*agrCA* and Δ*RNAIII* mutants indicates that the regulation of persister formation by Agr system is RNAIII independent. According to the study by [@B66] with RNA-seq analysis of 4-h cultures of *S. aureus* MW2 strain and its mutants of *agr* or *RNAIII*, Agr regulated genes that are RNAIII independent mainly consist of metabolism associated genes and PSM genes ([@B66]). Since the effects of AgrCA mutation were observed only in stationary phase, we performed RNA-seq with stationary phase cultures of USA500 and its mutants of *agrCA*, *agrD*, and *RNAIII*, to further investigate the RNAIII independent regulatory mechanisms of Agr system on persister formation.

As shown in the Heatmap (**Figure [2](#F2){ref-type="fig"}**), the three mutants caused significant changes to transcription of different genes, compared with the parent strain USA500. In the *agrCA* and *agrD* mutants, expression of metabolism genes including *bioA*, *pyrF*, and *nanK* were upregulated while several pathogenicity associated genes (*lip*, *lip1*, *splE*, and *splF*, etc.) were down regulated; meanwhile, the expression of PSM associated genes *hld*, *psmβ1*, *psmβ2*, *pmtR*, and *pmtB* were strongly repressed. Comparison of USA500ΔRNAIII with USA500ΔagrCA strain showed consistent down-regulation of virulence genes (*lip*, *lip1*, *splE*, and *splF*, etc.) and up-regulation of metabolism genes (*bioA*, *rpoE1*, and *nanK*, etc.), while unlike in USA500ΔagrCA, expression of *psmβ1*, *psmβ2*, *pmtR*, and *pmtB* in USA500ΔRNAIII were up regulated (Supplementary Tables [S2](#SM6){ref-type="supplementary-material"}, [S4](#SM7){ref-type="supplementary-material"}). It is worth mentioning that though the impact on gene expression by AgrD deletion was similar as that of AgrCA deletion, expression of several genes including *pulG* and *sarU* were regulated by AgrCA and AgrD differently (Supplementary Tables [S2](#SM6){ref-type="supplementary-material"}, [S3](#SM7){ref-type="supplementary-material"}).

![Transcriptional changes caused by mutation of *agrCA*, *agrD* and *RNAIII* in USA500. Based on results of RNA-seq, comparison (*p* \< 0.05) of transcriptional levels of each strain stress with that of USA500 are shown in columns. Genes up regulated in each deletion strain are represented in red, whilst genes down regulated in green. The enriched GO terms in the resulting clusters are shown. The map was painted with MEV software. A3, Δ*agrCA*; D4, Δ*agrD*; R5, Δ*RNAIII*; WT, wild type.](fmicb-08-02189-g002){#F2}

The RNA-seq results were validated by detecting transcription levels of several genes with Quantitative Real-time PCR. All samples showed similar fold change with those from RNA-seq results (**Figure [2](#F2){ref-type="fig"}**). The expression levels of the co-transcribed *psmα1-4* genes did not show up in RNA-seq data analysis of either strain, probably because the sizes of the four genes are too small to be included in the cDNA library. We detected mRNA level of *psmα* genes using primers for amplification of an 89-bp segment from the *psmα* operon, and found that the impact on PSMαs by depletion of *agrCA*, *agrD* or RNAIII were similar with that on PSMβs (**Figure [3](#F3){ref-type="fig"}**).

![Validation of RNA-seq by quantitative real-time PCR. Relative mRNA levels of transcripts from to USA500 and *agrCA*, *agrD* as well as *RNAIII* mutant strains mutant grown to 12--14 were determined. RNA was obtained from the same samples for RNA-seq. Bars show the fold change of each mutant vs. USA500 and error bars indicate standard deviations calculated with the 2^-ΔΔC~t~^ method based on three independent experiments.](fmicb-08-02189-g003){#F3}

The Functional Roles of PSMs in Agr Regulated Persister Formation
-----------------------------------------------------------------

Based on the observation of different impacts on persister formation by mutation of AgrCA and RNAIII, we hypothesized that the gene(s) are regulated differently by AgrCA and RNAIII. It has been reported that AgrCA strongly up-regulates while RNAIII down-regulates expression of PSMαs and PSMβs in post-exponential phase ([@B66]). Here we showed the similar trends with regulation of *psm* genes by Agr CA and RNAIII in stationary phase, where AgrCA up regulated and RNAIII down regulated expression of both *psmα1-4* and *psm*β*1-2* (**Figures [2](#F2){ref-type="fig"}**, **[3](#F3){ref-type="fig"}**).

We further constructed knockout strains *psmα1-4* or *psm*β*1-2*, which did not affect cell growth (**Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}**). Persister assay showed that for stationary cultures, knockout of *psmα1-4* or *psm*β*1-2* resulted in significant enhancement of persister formation, similar to the effects of *agrCA* knockout. In addition, complementation of *psmα1-4* or *psm*β*1-2* reversed promotion of persister formation of each mutant, respectively (**Figure [4A](#F4){ref-type="fig"}**).

![Phenol soluble modulins affect *S. aureus* persister formation. **(A,B)** Stationary phase USA500, knockout strains, complementary strains (based on pRB473) and overexpression strains (based on pRAB11) were treated with levofloxacin for 5 days. Results are representative of three independent experiments. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01; *t*-tests vs. corresponding control sample (Δ*agrCA*).](fmicb-08-02189-g004){#F4}

To investigate whether PSMs are the key factors in Agr regulated persister formation, we constructed overexpressing plasmids for *psmα1-4*, *psm*β*1-2* or both of them co-transcribed in one operon. Expressions of PSM genes are induced by ATc and not affected by absence of AgrA. Overexpression of *psmα1-4*, *psm*β*1-2* or both genes were capable of complementing the mutation of AgrCA on stationary phase persister formation, and the co-expressed PSMαs and PSMβs showed the strongest effects (**Figure [4B](#F4){ref-type="fig"}**). These results indicate that PSMαs and PSMβs are key downstream factors for persister regulation by the Agr system.

NanK Is Involved in Persister Formation and L-Form Formation
------------------------------------------------------------

Persister formation is closely related to dormancy with low metabolic state. To find more genes responsible for Agr-mediated persister formation, we picked eight more metabolism associated genes (*hutU*, *narG*, *arcA*, *arcR*, *mtlD*, *imrP*, *rhbC*, and *nanK*) (**Table [2](#T2){ref-type="table"}**) according to results of RNA-seq experiments performed by [@B66] and also by us. Among these genes only *nanK* mutant showed decreased persister formation to levofloxacin in stationary phase, compared with USA500 strain while knockout of *nanK* did not affect bacterial growth (**Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}**). In addition, the effects could be reversed by introduction of complementary plasmid pRBnanK (**Figure [5A](#F5){ref-type="fig"}**).

![Comparison of persister formation and L-form formation of *S. aureus* strains. **(A,B)** Stationary phase USA500, knockout strains, complementary strains (based on pRB473) and double mutants were treated with levofloxacin. Results are representative of three independent experiments. ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01; *t* tests vs. corresponding control (WT) samples. **(C)** *S. aureus* USA500 strain and its *nanK* mutant were plated on LIM. (C,D) L-form colonies observed under microscope at 400× magnification. The typical "fried egg" morphology can be observed from both strains.](fmicb-08-02189-g005){#F5}

Since *nanK* expression is strongly up regulated in USA500 Δ*agrCA* strain which showed enhanced persister formation, we seek to detect whether knockout of *nanK* could affect persister formation of USA500 Δ*agrCA*. However, the double mutant showed similar persister level with that of USA500ΔagrCA (**Figure [5B](#F5){ref-type="fig"}**).

Sialic acid metabolism is an important bioavailable energy source in stationary phase ([@B59]). The Neu5Ac catabolic pathway is a complex process catalyzing *N*-acetylneuraminic acid (Neu5Ac) into Fructose-6P (Fru-6P), which can be utilized in central metabolism or cell wall metabolism. NanK, the ManNAc kinase, phosphorylates ManNAc at the C-6 position to yield ManNAc-6P plays an important role in the pathway ([@B1]; [@B59]). To assess whether mutations of NanK or Agr system alter persister formation by affecting synthesis of ATP, intracellular ATP levels of stationary phase cultures of USA500 and its mutant strains of *nanK*, *agrCA*, *agrD*, *RNAIII*, *psmα1-4*, and *psm*β*1-2* were measured. However, no significant difference in ATP levels between these strains was found (**Supplementary Figure [S4](#SM4){ref-type="supplementary-material"}**).

We have found in our previous work that the glycerol uptake facilitator GlpF participates in both persister and L-form formation, indicating a close relationship between the two strategies bacteria use to survive challenge of antibiotics ([@B29]). Having found that NanK deletion attenuated persister formation, we sought to investigate whether NanK is also involved in L-form formation. As shown in **Figure [5C](#F5){ref-type="fig"}**, Δ*nanK* formed fewer L-form colonies, while the shape and size of individual bacterial cells were similar with that of the wild type strain.

Discussion
==========

*Staphylococcus aureus* persister mechanisms are different from those in *E. coli* persisters in several aspects. In *E. coli*, the influence of mutation of a gene on persister formation is generally consistent, with variations on growth phases or type of antibiotics. However, *S. aureus* persister genes often affect persister formation only in exponential phase or stationary phase ([@B29]; [@B79]). Also, the difference in persister formation can sometimes be observed when treated with specific antibiotics ([@B50]; [@B77]; [@B80]). We also showed in this study that the impacts on persister formation by AgrCA and Agr regulated genes were only found from treatment with levofloxacin. However, the underlying mechanisms for the difference between *S. aureus* and *E. coli* persister formation are far from being unveiled and require further study.

Agr is one of the master regulators of virulence in *S. aureus.* Mutations of Agr system genes have been shown to strongly attenuate virulence ([@B26]; [@B11]; [@B8]). Based on its importance, several studies have focused on developing anti-Agr strategies in *S. aureus*, and obvious repression of pathogenicity has been confirmed ([@B28]; [@B58]; [@B36]). However, though anti-Agr strategies seem promising, many groups have reported that Agr dysfunction promotes persistent bacteremia ([@B24]; [@B63]; [@B35]), permits abscess formation ([@B18]), and increases mortality among patients with *S. aureus* bacteremia, especially the most severe cases ([@B69]). The unexpected correlation of Agr dysfunction and worsened outcome of infection is intriguing and the reason remains unclear ([@B62]).

Previous studies showed that selection for loss of Agr-defective strains was mainly by healthcare environment including antibiotic treatment ([@B9]; [@B73]). A possible explanation is that, for unknown reasons, Agr dysfunction decreases vancomycin bactericidal activity ([@B67]; [@B75]). However, the impacts of Agr dysfunction on MIC of vancomycin were about two to four fold. Meanwhile, we did not observe MIC change of the *agrCA* mutant treated with vancomycin or any other antibiotics used in this study (**Table [3](#T3){ref-type="table"}**). Another hypothesis is that Agr dysfunction might help *S. aureus* escape host immune attack by reducing expression of multiple virulence genes regulated by Agr system ([@B48]). However, it is also reported that Agr dysfunction also promotes neutrophil lysis after phagocytosis ([@B74]). Therefore, the eventual outcome of interaction of host immune system and Agr dysfunction is yet to be determined.

###### 

Minimum inhibitory concentration (MIC) (μg/μl) of *Staphylococcus aureus* strains used in this study.

  Strains         Gentamicin   Levofloxacin   Oxacillin   Vancomycin
  --------------- ------------ -------------- ----------- ------------
  USA500          2            0.5            0.2         0.5
  USA500ΔagrCA    2            0.5            0.2         0.5
  USA500ΔagrD     2            0.5            0.2         0.5
  USA500ΔRNAIII   1            0.5            0.2         0.5
  USA500Δpsmα     2            0.5            0.2         0.5
  USA500Δpsmβ     2            0.5            0.2         0.5
  Newman          1            0.25           0.05        0.5
  NewmanΔagrCA    1            0.25           0.05        0.5
  HG003           1            0.25           0.1         0.5
  HG003ΔagrCA     1            0.25           0.1         0.5

Based on our study, we provide another possible explanation that Agr dysfunction might promote persistent infection by increasing persister formation through down-regulation of PSMαs and PSMβs in *S. aureus*. This is demonstrated by elevated persister formation of Agr mutants in our study. The multifunctional PSMs have been reported to help *S. aureus* cope with immune system by killing human neutrophils ([@B76]). PSMs also mediate maturation and detachment of late phase staphylococcal biofilms ([@B60]), which significantly promotes staphylococcal persister formation ([@B71]; [@B16]). Besides extracellular effects, PSMs also act as an intracellular signal to regulate gene expression. So far, PSMs have been found to bind only PmtR, which controls expression of genes in the *pmt* operon ([@B34]). More research is required to investigate whether PSMαs and PSMβs affect persister formation through PmtR, and if so, how PmtR regulate persister formation by controlling its target genes. Besides *in vitro* studies, more studies are required to address the regulation of persister formation by Agr system through PSMs in animal models, where the host immune system plays a role or additional antibiotic treatment may be applied to interrogate the role of Agr and PSM in persistent infection. Nonetheless, based on the clinical reports and our findings, we argue that the application of anti-Agr therapy should be more cautious especially when treating patients with persistent *S. aureus* infections, in particular for those with immunodeficiency.

We wondered what are the key factors in Agr mediated persister regulation. Agr system regulates different aspects of *S. aureus* biologic processes in both RNAIII dependent and RNA independent pathways. It is worth noticing that the study by [@B66] and our research showed that Agr and RNAIII regulate some genes including *psmα1-4* and *psm*β*1-2* in opposite ways, in both exponential phase and stationary phase, respectively. In addition, a recent study showed that δ-toxin regulates colony spreading by inhibiting PSM binding to *S. aureus* surface ([@B38]). The role of RNAIII/δ-toxin in PSM regulated persister formation is worth further research.

Entry into stationary phase has been reported to promote expression of genes involved in sialic catabolism ([@B59]). Among the metabolism associated genes we studied by knockout and persister assay, only knockout of *nanK*, which was down-regulated by AgrCA and RNAIII (**Figure [2](#F2){ref-type="fig"}**), attenuated persister formation and L-form formation (**Figure [5](#F5){ref-type="fig"}**). It has been reported that ATP depletion is a key reason for persister increase in stationary phase ([@B15]). However, no significant difference in ATP levels between Δ*nanK* and its parent strain was found (**Supplementary Figure [S4](#SM4){ref-type="supplementary-material"}**), indicating the existence of other persister mechanisms independent of ATP depletion as being involved in Agr mediated persister formation in *S. aureu*s. In addition, since sialic acid is more abundant in mucosa of hosts than in TSB ([@B49]), the role of the sialic acid metabolism plays in Agr mediated persister formation might be more important *in vivo* and is worth further investigation in animal models.

L-form is an intriguing phenomenon and its mechanisms are not well unveiled in *S. aureus* ([@B61]; [@B51]). Since L-form formation is closely related to cell wall integrity, a likely reason for NanK's role in L-form formation is that NanK deletion decreased the production of Fru-6-P, which is a substrate for synthesis of UDP-GlcNAc, a crucial molecule for cell wall building. Combined with our previous findings with GlpF ([@B29]), our finding that NanK deletion attenuated both persister formation and L-form formation indicates the close relationship between formation of L-forms and persisters ([@B81]).

In summary, by screening persister associated genes we showed that Agr system plays an important role in persister formation as seen by elevated persister levels in Agr mutants, in addition to its role in controlling virulence factors (**Figure [6](#F6){ref-type="fig"}**). The regulation of persister formation by Agr system is mainly carried out by PSMs. We also investigated the regulatory role of Agr system in sialic acid metabolism, which participates in persister formation and L-form formation. Our findings provide new insights into the biology of *S. aureus* persister formation and provides a possible explanation for the worsened bacteremia by Agr dysfunction in clinical treatments.

![Regulation of persister formation is part of the Agr quorum-sensing regulatory network. The *agr* operon encodes a signal molecule AIP from P2 promoter and a regulatory RNA molecule RNAIII from P3 promoter. While AgrA up-regulates expression of P2, P3, NanK, and PSM expression, RNAIII negatively regulate NanK and PSM expression. NanK is involved in sialic metabolism and persister formation. PSMαs and PSMβs represses persister formation through unclear mechanisms. The "P" between AgrC and AgrA indicates phosphorylation.](fmicb-08-02189-g006){#F6}
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**(A--D)** Exponential phase culture of USA500 and knockout mutants were treated with levofloxacin, oxacillin, gentamicin or vancomycin. **(E)** Persister levels of stationary phase cultures of USA500 and mutants. Results are representative of three independent experiments.
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Growth curve of USA500 and the two knockout mutants of *psmα1-4* and *psm*β*1-2*.
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Growth curve of USA500 and the its knockout mutants of *nanK*.
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###### 

Intracellular concentration of ATP in stationary phase USA500 and mutant strains. The values were adjusted according to the CFU count of each sample.
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MIC

:   minimum inhibitory concentration

MRSA

:   methicillin resistant *Staphylococcus aureus;*

MSSA

:   methicillin susceptible *Staphylococcus aureus*

PSM

:   phenol soluble modulins

QS

:   quorum sensing

TCS

:   two-component signal transduction system.
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